Is EMS-CHEMIE HOLDING (SWX:EMSN) Fully Valued On Higher Half Year Profitability?

Recent earnings event and what changed in the EMS-CHEMIE HOLDING story

EMS-CHEMIE HOLDING (SWX:EMSN) just reported half year 2026 results, with sales at CHF 1,010.06 million versus CHF 1,019.59 million a year earlier, while net income reached CHF 258.29 million and earnings per share rose to CHF 11.04.

That mix of slightly softer sales and higher profitability provides a clearer view of how the business is managing costs and pricing, which helps frame any assessment of the recent share performance.

EMS-CHEMIE HOLDING’s share price has climbed 44.64% year to date and delivered a 33.81% one year total shareholder return, while a 15.29% 90 day share price gain alongside a 3.98% 30 day pullback suggests momentum that is strong but taking a breather after this earnings update.

Compare EMS-CHEMIE HOLDING’s post-earnings momentum with other quality plays by scanning our handpicked list of 617 high quality undiscovered gems for ideas that may still be under the radar.

After a 44.64% year to date jump and firmer earnings on flatter sales, EMS-CHEMIE HOLDING now forces a simple question: Is the bigger payoff still ahead, or has most of the upside already been used up in the recent move?

Price-to-earnings of 39.2x for EMS-CHEMIE HOLDING: Is it justified?

At CHF795.50, EMS-CHEMIE HOLDING trades on a P/E of 39.2x. This looks rich compared with peers and suggests the market is paying a premium for each franc of current earnings.

The P/E ratio compares the share price to earnings per share and is a common yardstick for mature, profitable businesses like EMS-CHEMIE HOLDING. A higher multiple often reflects investors expecting steadier profitability or resilient cash generation rather than rapid expansion.

For this stock, the premium is clear. The current 39.2x P/E sits well above the peer average of 23.7x and also above the European Chemicals industry average of 17.6x. The estimated fair P/E of 26.1x is much lower than where the shares currently trade. This points to a valuation level the market could shift toward if sentiment or growth expectations cool.

Explore the SWS fair ratio for EMS-CHEMIE HOLDING.

Result: Price-to-earnings of 39.2x (OVERVALUED)

Still, EMS-CHEMIE HOLDING’s premium P/E and heavy revenue base in Switzerland and Europe leave the story exposed if demand or pricing weakens.

Find out about the key risks to this EMS-CHEMIE HOLDING narrative.

Another view on EMS-CHEMIE HOLDING’s valuation

The premium P/E tells one story, but the SWS DCF model offers a different angle. On that cash flow view, EMS-CHEMIE HOLDING at CHF795.50 sits above an estimated value of CHF672.93, which also points to an expensive tag. If both earnings and cash flow signals suggest a rich valuation, what factors might make you comfortable paying this price?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out EMS-CHEMIE HOLDING for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 180 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed signals on EMS-CHEMIE HOLDING’s valuation story, or just a crowded trade catching up with expectations? If you want to move quickly and shape your own view based on the positives the market is watching, start with the 2 key rewards.

Looking for more EMS-CHEMIE HOLDING sized investment ideas?

If you rate EMS-CHEMIE HOLDING but do not want to lean on a single stock, use the Simply Wall St screener to broaden your opportunity set efficiently.

• Target potential bargains with resilient financial profiles by scanning our handpicked 180 high quality undervalued stocks that combine quality metrics with appealing pricing signals.
• Build income-focused exposure by reviewing a curated group of 167 dividend fortresses that aim to balance payout strength with underlying business stability.
• Sleep a little easier by concentrating on companies screened as 97 resilient stocks with low risk scores so you can focus attention where volatility might matter most.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com